About Avantis

For over a decade, Avantis Medical Systems has been a leader in cancer screening and detection. The company has developed a platform technology utilizing advanced optics, imaging, and software analysis for the screening and early detection of cancer, with colorectal cancer (CRC) as its first clinical application.

Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths throughout the world. According to the American Cancer Society, approximately 150,000 people in the U.S. are diagnosed with CRC each year, and almost 50,000 die from it.

Colonoscopy allows CRC to be found earlier, when the disease is easier to cure, and cancers can be prevented if adenomas are removed before they become malignant. Avantis recently launched its newest generation product, the Third Eye® Panoramic™ device, which is a wide-angle visualization tool designed to provide gastroenterologists and other endoscopists a better look at areas where cancers and pre-cancerous polyps may be hidden from the view of a traditional colonoscope alone. Studies have shown that wide-angle visualization devices can greatly increase adenoma detection.1

Our Third Eye Panoramic device allows health care professionals to perform more complete colonoscopies through better visualization. The device has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) and is now commercially available in the USA.

Avantis has an extensive portfolio of patents covering innovative devices based on the convergent technologies of micro-chips and enhanced video processing systems. To date, the Company has 13 issued patents and 13 patents pending. Avantis has pending patent applications in the U.S. and international markets specifically directed to core Third Eye technologies, as well as a foundational issued patent in Japan.

1.  Gralnek IM, Siersema PD, Rex DK, et al. Standard forward-viewing colonoscopy versus full-spectrum endoscopy: an international, multicentre, randomised, tandem colonoscopy trial. Lancet Oncol 2014;15:353-60.

Management Team

Anthony DiTonno

President and CEO

Tony brings over 20 years of senior leadership experience spanning the pharmaceutical and medical device industries with companies such as NeurogesX and LifeSleep, where he served as CEO for both companies, Enteric Medical Technologies, Oclassen Pharmaceuticals and Wyeth Laboratories.

Jack Higgins, MD

Chief Medical Officer

Dr. Higgins has more than 30 years of clinical experience and was formerly a clinical faculty member at Stanford University and University of California, Davis.

Salmaan Hameed

Vice President, Research and Development

Over 20 years of R&D experience in medical device companies including Chest Innovations, Stryker Endoscopy and CIRCON-ACMI.

Doug Gielow

Vice President, Sales & Marketing

Doug’s sales and marketing experience in medical device companies includes Stryker Endoscopy, Barrx Medical, Gyrus-ACMI and Abbott Laboratories.

Investors